[Comparative study of the use of crystalloids and colloids in the therapy of burn shock].
D010129:4-Aminobenzoic Acid / Q000627:therapeutic use; D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D014151:Anti-Anxiety Agents / Q000627:therapeutic use; D000933:Antifibrinolytic Agents / Q000627:therapeutic use; D007611:Aprotinin / Q000627:therapeutic use; D001569:Benzodiazepines; D001803:Blood Transfusion; D002056:Burns / Q000188:drug therapy*; D003102:Colloids / Q000627:therapeutic use; D004573:Electrolytes / Q000627:therapeutic use; D006634:Histamine H1 Antagonists / Q000627:therapeutic use; D006801:Humans; D009020:Morphine / Q000627:therapeutic use; D010949:Plasma; D010952:Plasma Substitutes / Q000627:therapeutic use; D012774:Shock, Traumatic / Q000188:drug therapy*; D012835:Silver Nitrate / Q000627:therapeutic use; D062366:para-Aminobenzoates
D000305:Adrenal Cortex Hormones; D014151:Anti-Anxiety Agents; D000933:Antifibrinolytic Agents; D003102:Colloids; D004573:Electrolytes; D006634:Histamine H1 Antagonists; D010952:Plasma Substitutes; D062366:para-Aminobenzoates; D001569:Benzodiazepines; C015668:4-aminomethylbenzoic acid; D009020:Morphine; D007611:Aprotinin; D012835:Silver Nitrate; D010129:4-Aminobenzoic Acid
Studio comparato sull'uso dei cristalloidi e dei colloidi nella terapia dello shock da ustione.